EZR and breast carcinoma: In this connection, a number of clinical studies have highlighted that ezrin is involved in tumor progression, especially metastasis [13], in osteosarcoma [14], lung cancer [15], tongue squamous cell carcinoma [16], breast cancer [17], pancreatic cancer [18], and uterine cervical cancer [19].